Edition:
India

Evofem Biosciences Inc (EVFM.OQ)

EVFM.OQ on NASDAQ Stock Exchange Capital Market

6.27USD
19 Apr 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.27
Open
$6.23
Day's High
$6.27
Day's Low
$5.81
Volume
1,060
Avg. Vol
5,416
52-wk High
$15.60
52-wk Low
$1.80

Latest Key Developments (Source: Significant Developments)

Evofem Biosciences Files For Common Stock Offering Of Up To $57.5 Mln
Saturday, 7 Apr 2018 

April 6 (Reuters) - Evofem Biosciences Inc ::EVOFEM BIOSCIENCES FILES FOR COMMON STOCK OFFERING OF UP TO $57.5 MLN - SEC FILING.  Full Article

Neothetics to pay $1.5 mln‍​‍​ to Evofem Biosciences if deal terminated
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Neothetics Inc :Neothetics says if merger agreement with Evofem Biosciences terminated under specified circumstances, co to pay Evofem termination fee of up to $1.5 mln‍​‍​.  Full Article

Neothetics Inc and Evofem Biosciences Inc announce merger agreement to create Women’S health company
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Neothetics Inc :Neothetics Inc and Evofem Biosciences, Inc. announce merger agreement to create Women’S health company.Neothetics Inc - ‍privately-held Evofem Biosciences will merge with a wholly-owned subsidiary of Neothetics in an all-stock transaction​.Neothetics - ‍Invesco Asset Management entered securities purchase agreement to acquire additional $20 million of common stock in combined Co​.Neothetics Inc - ‍transactions have been approved by board of directors of both companies​.Neothetics - Neothetics will be renamed Evofem Biosciences and will be under leadership of Evofem Biosciences' CEO Saundra Pelletier​.Neothetics Inc - merger ‍exchange ratio assumes $171.4 million in value of Co's common stock will be issued to Evofem Biosciences stockholders in merger​.Neothetics - current Neothetics stockholders to own about 13% of combined company & current Evofem stockholders to own about 87% of combined company​.Neothetics Inc - ‍merger exchange ratio assumes $28.6 million in value of common stock being retained by Neothetics stockholders​.Neothetics Inc - ‍following merger, company will be led by Saundra Pelletier as chief executive officer​.  Full Article

Neothetics reports Q1 loss per share $0.44
Thursday, 12 May 2016 

Neothetics Inc : Neothetics reports first quarter 2016 financial results .Q1 loss per share $0.44.  Full Article

BRIEF-Evofem Biosciences Receives Fast Track Designation For Amphora For Prevention Of Chlamydia

* EVOFEM BIOSCIENCES RECEIVES FAST TRACK DESIGNATION FOR AMPHORA FOR PREVENTION OF CHLAMYDIA